The acquired hemophilia treatment market is witnessing steady growth as healthcare providers increasingly focus on improving the diagnosis and management of this rare autoimmune bleeding disorder. Acquired hemophilia occurs when the body's immune system develops inhibitors against clotting factor VIII, resulting in spontaneous and potentially life-threatening bleeding episodes. Growing...